London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies ...

The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...

DETROIT -- Detroit Tigers slugger Spencer Torkelson will get a day off on Wednesday night. The Tigers (28-15) wrap up a three ...

GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...

Rock Bridge football tight end Garrett Essner chose Memphis over notable programs like Army, UNLV, USF and Kent State.

Detroit Tigers first baseman/designated hitter Spencer Torkelson is getting a breather in Wednesday's game against the ...

GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion ...

MLB player prop bets and odds for Spencer Enochs Torkelson on Wednesday, May 14, 2025, as the Detroit Tigers take on the ...

Under the agreement, GSK will acquire BP Asset IX, a subsidiary of Boston Pharmaceuticals, for up to $2 billion in total cash ...

Boston Scientific recently shared new clinical data sets on the use of its Eluvia drug-eluting stent for treating peripheral ...

With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver ...

GSK will acquire Boston Pharmaceuticals’ lead asset, efimosfermin alfa, a phase III-ready investigational specialty medicine.